comparemela.com

Latest Breaking News On - From calluna pharmajan - Page 1 : comparemela.com

Calluna Pharma launches and announces EUR 75 million Series A financing to develop novel therapies for inflammatory and fibrotic diseases

Oxitope Pharma (Oxitope) and Arxx Therapeutics (Arxx), companies with a shared goal of leveraging the innate immune system to discover and develop disease modulating therapies, today announced their merger to form Calluna Pharma Inc. (Calluna).

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.